LataMed AI Corp. (OTC: LMED), a development-stage digital health and artificial intelligence technology company, provided an update on its attendance at HLTH Europe 2026, a leading healthcare innovation conference. Management reported that the event offered valuable opportunities to engage with healthcare innovators, technology companies, insurers, and digital health organizations from Europe, Latin America, and other international markets.
The company noted that the conference reinforced its belief that healthcare systems increasingly require integrated digital solutions capable of improving patient accessibility, care coordination, financial accessibility, and operational efficiency. Management observed growing interest across the healthcare sector in artificial intelligence applications, telehealth infrastructure, healthcare payments, insurance accessibility initiatives, and technology-enabled patient engagement solutions.
Dr. Kevin Rodan Levy, Chief Executive Officer, stated: “HLTH Europe provided an outstanding opportunity to engage with healthcare and technology professionals from across Europe, Latin America, and other international markets. One of the most encouraging takeaways from the conference was the growing industry focus on integrated healthcare platforms that combine accessibility, coordination, financial solutions, and technology-enabled patient engagement. We believe many of these trends align closely with the direction of our broader healthcare ecosystem strategy and reinforce our long-term vision for LataMed AI.”
Management further noted that the conference provided valuable visibility for its platform initiatives and an opportunity to establish new industry relationships that may support future growth objectives. The company believes many of the themes discussed align closely with its ongoing efforts to develop an integrated healthcare ecosystem that combines telehealth infrastructure, healthcare coordination technologies, payment accessibility initiatives, insurance integration opportunities, pharmacy-related services, and AI-driven healthcare solutions.
The company stated it is currently reviewing and evaluating various follow-up opportunities resulting from discussions held during the conference and intends to provide additional updates regarding any material developments as appropriate. Photographs and highlights from the company's attendance at HLTH Europe 2026 are available through LataMed AI's official Instagram page. For additional information, please visit https://latamed.ai or review the company’s filings with the U.S. Securities and Exchange Commission at www.sec.gov.
Forward-looking statements in this press release are based on current expectations and assumptions, subject to significant risks and uncertainties. Actual results may differ materially due to factors including the company's ability to implement its business plan, availability of financing, regulatory authorizations, operational execution risks, technology deployment risks, and general economic conditions.
